Bausch Health Companies Inc. (BHC) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 2.49B | 2.84B | 2.65B | 2.57B | 2.25B | 2.56B | 2.51B | 2.4B | 2.15B | 2.41B | 2.24B | 2.17B |
| Revenue Growth % | 10.52% | 10.94% | 5.61% | 7.09% | 4.61% | 6.27% | 12.15% | 10.89% | 10.75% | 9.8% | 9.38% | 10.17% |
| Cost of Goods Sold | 965.44M | 1.05B | 991.74M | 1.04B | 954.11M | 727M | 696M | 719M | 640M | 705M | 623M | 649M |
| COGS % of Revenue | 38.79% | 36.98% | 37.41% | 40.32% | 42.36% | 28.41% | 27.73% | 29.92% | 29.73% | 29.28% | 27.84% | 29.95% |
| Gross Profit | 1.52B | 1.79B | 1.66B | 1.54B | 1.3B | 1.83B | 1.81B | 1.68B | 1.51B | 1.7B | 1.61B | 1.52B |
| Gross Margin % | 61.21% | 63.02% | 62.59% | 59.68% | 57.64% | 71.59% | 72.27% | 70.08% | 70.27% | 70.72% | 72.16% | 70.05% |
| Gross Profit Growth % | 17.37% | -2.34% | -8.54% | -8.8% | -14.21% | 7.57% | 12.32% | 10.94% | 11.09% | 10.51% | 10.47% | 9.21% |
| Operating Expenses | 1.01B | 1.06B | 950.21M | 1.07B | 1.01B | 1.27B | 1.5B | 1.29B | 1.23B | 1.34B | 1.6B | 1.11B |
| OpEx % of Revenue | 40.57% | 37.3% | 35.84% | 41.62% | 44.71% | 49.79% | 59.6% | 53.89% | 57.22% | 55.69% | 71.54% | 51.04% |
| Selling, General & Admin | 849.07M | 895.56M | 786.08M | 909.29M | 864.38M | 816M | 850M | 832M | 789M | 762M | 715M | 711M |
| SG&A % of Revenue | 34.11% | 31.55% | 29.65% | 35.34% | 38.38% | 31.89% | 33.86% | 34.62% | 36.65% | 31.64% | 31.95% | 32.81% |
| Research & Development | 160.74M | 163.47M | 164.14M | 161.72M | 142.57M | 163M | 161M | 159M | 151M | 152M | 153M | 156M |
| R&D % of Revenue | 6.46% | 5.76% | 6.19% | 6.28% | 6.33% | 6.37% | 6.41% | 6.62% | 7.01% | 6.31% | 6.84% | 7.2% |
| Other Operating Expenses | 1 | 1 | 1 | 0 | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Operating Income | 513.78M | 730.05M | 708.95M | 464.82M | 291.12M | 558M | 318M | 389M | 281M | 362M | 14M | 412M |
| Operating Margin % | 20.64% | 25.72% | 26.74% | 18.06% | 12.93% | 21.81% | 12.67% | 16.19% | 13.05% | 15.03% | 0.63% | 19.01% |
| Operating Income Growth % | 76.49% | 30.83% | 122.94% | 19.49% | 3.6% | 54.14% | 2171.43% | -5.58% | 60.57% | 253.39% | -94.26% | 155.9% |
| EBITDA | 804.7M | 1.02B | 1.01B | 777.07M | 595.2M | 865M | 640M | 707M | 601M | 691M | 315M | 727M |
| EBITDA Margin % | 32.33% | 36.09% | 38.16% | 30.2% | 26.43% | 33.8% | 25.5% | 29.42% | 27.91% | 28.7% | 14.08% | 33.55% |
| EBITDA Growth % | 35.2% | 18.44% | 58.05% | 9.91% | -0.97% | 25.18% | 103.17% | -2.75% | 21.66% | 457.26% | -45.6% | 43.11% |
| D&A (Non-Cash Add-back) | 290.91M | 294.46M | 302.57M | 312.25M | 304.08M | 307M | 322M | 318M | 320M | 329M | 301M | 315M |
| EBIT | 513.78M | 730.05M | 708.95M | 464.82M | 291.12M | 594M | 544M | 426M | 299M | 507M | 494M | 381M |
| Net Interest Income | -386.57M | -395.99M | -394.52M | -462.78M | -321.03M | -328M | -339M | -342M | -346M | -356M | -333M | -312M |
| Interest Income | 9.86M | 9.14M | 14.83M | 13.22M | 10.97M | 9M | 7M | 8M | 9M | 7M | 6M | 7M |
| Interest Expense | 396.43M | 405.13M | 409.35M | 476M | 331.99M | 337M | 346M | 350M | 355M | 363M | 339M | 319M |
| Other Income/Expense | -1.85B | -673.19M | -493.4M | -322.42M | -337.98M | -349M | -339M | -341M | -350M | -369M | -340M | -333M |
| Pretax Income | -1.34B | 56.86M | 215.55M | 142.39M | -46.86M | 209M | -21M | 47.99M | -69M | -7M | -326M | 79M |
| Pretax Margin % | -53.64% | 2% | 8.13% | 5.53% | -2.08% | 8.17% | -0.84% | 2% | -3.2% | -0.29% | -14.57% | 3.65% |
| Income Tax | 75.93M | 161.44M | 36.58M | 12.21M | 38.88M | 111M | 71M | 48.99M | 7.96M | 40M | 56M | 52M |
| Effective Tax Rate % | -5.69% | 283.93% | 16.97% | 8.57% | -82.98% | 53.11% | -338.1% | 102.08% | -11.54% | -571.43% | -17.18% | 65.82% |
| Net Income | -1.4B | -113.72M | 176.99M | 150.53M | -57.82M | 93M | -85M | 10M | -63.71M | -39M | -378M | 26M |
| Net Margin % | -56.38% | -4.01% | 6.68% | 5.85% | -2.57% | 3.63% | -3.39% | 0.42% | -2.96% | -1.62% | -16.89% | 1.2% |
| Net Income Growth % | -2326.8% | -222.28% | 308.22% | 1405.31% | 9.24% | 338.46% | 77.51% | -61.54% | 68.3% | 90.49% | -194.74% | 117.93% |
| Net Income (Continuing) | -1.41B | -104.58M | 178.97M | 130.19M | -85.74M | 98M | -92M | -1M | -77M | -47M | -382M | 27M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 977M | 929.31M | 920.1M | 911M | 943M | 957M | 932M | 948M | 941M | 940M | 945M | 705.06M |
| EPS (Diluted) | -3.79 | -0.31 | 0.47 | 0.40 | -0.16 | 0.25 | -0.23 | 0.03 | -0.17 | -0.11 | -1.03 | 0.07 |
| EPS Growth % | -2268.75% | -224% | 304.35% | 1381.48% | 5.88% | 327.27% | 77.67% | -62.34% | 70.69% | 90.27% | -193.64% | 118.87% |
| EPS (Basic) | -3.79 | -0.31 | 0.48 | 0.41 | -0.16 | 0.25 | -0.23 | 0.03 | -0.17 | -0.11 | -1.03 | 0.07 |
| Diluted Shares Outstanding | 372.8M | 370.53M | 375.5M | 373.1M | 369.6M | 372M | 368.4M | 370.2M | 366.8M | 365.24M | 365.4M | 367.1M |
| Basic Shares Outstanding | 372.8M | 370.53M | 371.3M | 370.9M | 369.6M | 372M | 368.4M | 367.9M | 366.8M | 365.24M | 365.4M | 364.8M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |